↓ Skip to main content

Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study

Overview of attention for article published in Frontiers in Pharmacology, September 2024
Altmetric Badge

Mentioned by

reddit
1 Redditor